CEO: Christopher Anzalone

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.


Key numbers

Market Capitalization:4521079440
Shares Outstanding: 95301000
Float: 88881810.543
Next Earning Date:2019-11-25
TTm EPS: 0.4786
TTm Dividend Rate:
200 days moving average:26.26
50 days moving average: 34.75
One day percent Change: 23.06



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-09-30, 2016-09-30, 2017-09-30, 2018-09-30,
2015-09-30, 2016-09-30, 2017-09-30, 2018-09-30,